Pathology Analysis & Statistics, December 2014 (p30)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

871-900 of about 6 500 reports

Purchase Reports From Reputable Market Research Publishers

Xeljanz (tofacitinib) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Xeljanz (tofacitinib) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Xeljanz (tofacitinib) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Iguratimod/T-614 (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Iguratimod/T-614 (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Iguratimod/T-614 (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Pharmaceutical
Sarilumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Sarilumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Sarilumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Pharmaceutical
Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Pharmaceutical
Clazakizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Clazakizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Clazakizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Pharmaceutical
Cosentyx (secukinumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Cosentyx (secukinumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Cosentyx (secukinumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ...

  • Industries : Pharmaceutical
Tregalizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Tregalizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Tregalizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Pharmaceutical
Mavrilimumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Mavrilimumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Mavrilimumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Pharmaceutical
Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ...

  • Industries : Pharmaceutical, Biopharmaceutical
Baricitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Baricitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Baricitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Pharmaceutical
Peficitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Peficitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Peficitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Pharmaceutical
Decernotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Decernotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Decernotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Pharmaceutical
Filgotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Filgotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Filgotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Pharmaceutical
Masitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Masitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Masitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Pharmaceutical
Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

  • $ 4 995
  • Industry report
  • December 2014
  • by GBI Research

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth Summary Increasingly Crowded Market for Second-Line Therapies Improving Treatment Options for Moderate-to-Severe Rheumatoid ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • December 2014
  • by GBI Research

Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation Summary Large and Diverse Pipeline The liver cancer pipeline contains 238 products in active development, approximately ...

  • Industries : General Medicine and Specialty Medicine, Pathology
  • Countries : Europe
The Market for Home Care Products

The Market for Home Care Products

  • $ 3 995
  • Industry report
  • December 2014
  • by Kalorama Information

Demand in the U.S. market for home care products and equipment continues to rise, with an aging population and an ongoing shift of chronic care patients from hospitals to home. New medical-technology devices ...

  • Industries : Medical Devices, Healthcare, Medical Facility, Medical Equipment and Supply, Caring Services
  • Countries : United States
Optic Neuritis - Pipeline Review, H2 2014

Optic Neuritis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Optic Neuritis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Optic Neuritis - Pipeline Review, H2 2014’, provides an overview of the Optic Neuritis’s therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : United States
Biliary Cirrhosis - Pipeline Review, H2 2014

Biliary Cirrhosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Biliary Cirrhosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Biliary Cirrhosis - Pipeline Review, H2 2014’, provides an overview of the Biliary Cirrhosis’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World, Europe
Sinusitis - Pipeline Review, H2 2014

Sinusitis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Sinusitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Sinusitis - Pipeline Review, H2 2014’, provides an overview of the Sinusitis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Drug and Medication, Healthcare
  • Countries : United States, World
Bronchitis - Pipeline Review, H2 2014

Bronchitis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Bronchitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Bronchitis - Pipeline Review, H2 2014’, provides an overview of the Bronchitis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World
Acute Spinal Cord Injury - Pipeline Review, H2 2014

Acute Spinal Cord Injury - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Acute Spinal Cord Injury - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Acute Spinal Cord Injury - Pipeline Review, H2 2014’, provides an overview of the Acute Spinal Cord Injury’s ...

  • Industries : Pathology
  • Countries : United States
Pemphigus - Pipeline Review, H2 2014

Pemphigus - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Pemphigus - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Pemphigus - Pipeline Review, H2 2014’, provides an overview of the Pemphigus’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World
Lipodystrophy - Pipeline Review, H2 2014

Lipodystrophy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Lipodystrophy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Lipodystrophy - Pipeline Review, H2 2014’, provides an overview of the Lipodystrophy’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Anal Cancer - Pipeline Review, H2 2014

Anal Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Anal Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Anal Cancer - Pipeline Review, H2 2014’, provides an overview of the Anal Cancer’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical
  • Countries : United States, World
Salivary Gland Cancer - Pipeline Review, H2 2014

Salivary Gland Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Salivary Gland Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Salivary Gland Cancer - Pipeline Review, H2 2014’, provides an overview of the Salivary Gland Cancer’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World
Oligodendroglioma - Pipeline Review, H2 2014

Oligodendroglioma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Oligodendroglioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H2 2014’, provides an overview of the Oligodendroglioma’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Septic Shock - Pipeline Review, H2 2014

Septic Shock - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Septic Shock - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Septic Shock - Pipeline Review, H2 2014’, provides an overview of the Septic Shock’s therapeutic pipeline. This report ...

  • Industries : Research and Development, Pharmaceutical, Pathology, Drug and Medication
  • Countries : United States
Pancreatitis Global Clinical Trials Review, H2, 2014

Pancreatitis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Pancreatitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pancreatitis Global Clinical Trials Review, H2, 2014" provides data on the Pancreatitis clinical trial ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Pathology, Therapy
  • Countries : World
About 58 000 reports

Download Unlimited Documents from Trusted Public Sources

Pharmacy Industry in the UK

  • April 2015
    125 pages
  • Pharmacy  

    Community Pharm...  

    Occupational He...  

  • United Kingdom  

    Europe  

    United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.